Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Brain Computer Interface: Neuroprosthetic Control of a Motorized Exoskeleton

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The BCI project falls within the very broad field of brain machine interfaces. Its multiple applications include the compensation of motor deficits. The subject of the present protocol is the first test of the system in man on the compensation of motor deficits by an epidural brain implant enabling an electrocorticogram (EcoG) to be recorded.

Who May Be Eligible (Plain English)

Who May Qualify: - Male or female aged between 18 and 45 years - Stability of neurological deficits in accrued sequelae - Lack of adequate compensation for the deficits in terms of quality of life. In other words, the expression by the patient of a need for additional mobility, oriented towards greater autonomy - Ambulatory or hospitalized monitoring - Fluent in French and able to understand the study procedures, including completing the auto-questionnaires - Registered in the French social security scheme - Signed willing to sign a consent form of the patient will be collected before inclusion in the study Who Should NOT Join This Trial: - Previous brain surgery, - Chronic prescription of anticoagulant treatments, - Impaired neuropsychological sequelae from an associated head injury, - Depressive syndrome with or without suicide attempt. - Alcohol or other substance dependence in the last 12 months, with abuse in the - A complete assessment (neurological and neuropsychological) will be conducted among eligible patients. - Contraindication to Magnetoencephalography (MEG) and/or Electroencephalography (EEG) - Contraindication to Magnetic resonance imaging (MRI) Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Male or female aged between 18 and 45 years * Stability of neurological deficits in accrued sequelae * Lack of adequate compensation for the deficits in terms of quality of life. In other words, the expression by the patient of a need for additional mobility, oriented towards greater autonomy * Ambulatory or hospitalized monitoring * Fluent in French and able to understand the study procedures, including completing the auto-questionnaires * Registered in the French social security scheme * Signed informed consent of the patient will be collected before inclusion in the study Exclusion Criteria: * Previous brain surgery, * Chronic prescription of anticoagulant treatments, * Impaired neuropsychological sequelae from an associated head injury, * Depressive syndrome with or without suicide attempt. * Alcohol or other substance dependence in the last 12 months, with abuse in the - A complete assessment (neurological and neuropsychological) will be conducted among eligible patients. * Contraindication to Magnetoencephalography (MEG) and/or Electroencephalography (EEG) * Contraindication to Magnetic resonance imaging (MRI)

Treatments Being Tested

DEVICE

Brain-computer interface (BCI) platform including two implanted remotely powered ElectroCorticoGraph (ECoG) recording devices and an exoskeleton

Locations (1)

CLINATEC
Grenoble, France